메뉴 건너뛰기




Volumn 144, Issue 2, 2015, Pages 254-262

Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis

Author keywords

Apoptosis; Barrier function; CD52 monoclonal antibody; Crohn's disease; Interleukin 10 knockout; Tight junction

Indexed keywords

ALEMTUZUMAB; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; ZONULA OCCLUDENS PROTEIN; CD52 ANTIGEN; GLYCOPROTEIN; IL10 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; OCLN PROTEIN, MOUSE; PROTEIN ZO1; TJP1 PROTEIN, MOUSE; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

EID: 84922588873     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12366     Document Type: Article
Times cited : (21)

References (47)
  • 1
    • 77955741321 scopus 로고    scopus 로고
    • Effects of T cell-induced colonic inflammation on epithelial barrier function
    • Suenaert P, Maerten P, Van Assche G et al. Effects of T cell-induced colonic inflammation on epithelial barrier function. Inflamm Bowel Dis 2010; 16:1322-31.
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 1322-1331
    • Suenaert, P.1    Maerten, P.2    Van Assche, G.3
  • 2
    • 84878258216 scopus 로고    scopus 로고
    • Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice
    • Azuma T, Shigeshiro M, Kodama M Tanabe S, Suzuki T. Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr 2013; 143:827-34.
    • (2013) J Nutr , vol.143 , pp. 827-834
    • Azuma, T.1    Shigeshiro, M.2    Kodama, M.3    Tanabe, S.4    Suzuki, T.5
  • 3
    • 84876404920 scopus 로고    scopus 로고
    • Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon
    • Juric M, Xiao F, Amasheh S et al. Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon. Inflamm Bowel Dis 2013; 19:904-11.
    • (2013) Inflamm Bowel Dis , vol.19 , pp. 904-911
    • Juric, M.1    Xiao, F.2    Amasheh, S.3
  • 4
    • 84881030277 scopus 로고    scopus 로고
    • Complex roles of caspases in the pathogenesis of inflammatory bowel disease
    • Becker C, Watson AJ, Neurath MF. Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 2013; 144:283-93.
    • (2013) Gastroenterology , vol.144 , pp. 283-293
    • Becker, C.1    Watson, A.J.2    Neurath, M.F.3
  • 5
    • 85028094075 scopus 로고    scopus 로고
    • Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease
    • Schumann M, Gunzel D, Buergel N et al. Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease. Gut 2012; 61:220-8.
    • (2012) Gut , vol.61 , pp. 220-228
    • Schumann, M.1    Gunzel, D.2    Buergel, N.3
  • 6
    • 84880611949 scopus 로고    scopus 로고
    • TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis
    • Su L, Nalle SC, Shen L et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 2013; 145:407-15.
    • (2013) Gastroenterology , vol.145 , pp. 407-415
    • Su, L.1    Nalle, S.C.2    Shen, L.3
  • 7
    • 0027521572 scopus 로고
    • Interleukin-10-deficient mice develop chronic enterocolitis
    • Kuhn R, Lohler J, Rennick D Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
    • (1993) Cell , vol.75 , pp. 263-274
    • Kuhn, R.1    Lohler, J.2    Rennick, D.3    Rajewsky, K.4    Muller, W.5
  • 9
    • 83555172379 scopus 로고    scopus 로고
    • The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease
    • Wang L, Trebicka E, Fu Y et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:112-9.
    • (2012) Inflamm Bowel Dis , vol.18 , pp. 112-119
    • Wang, L.1    Trebicka, E.2    Fu, Y.3
  • 10
    • 84879805222 scopus 로고    scopus 로고
    • Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis
    • Yin H, Li X, Zhang B, et al. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. Immunology 2013; 139:494-502.
    • (2013) Immunology , vol.139 , pp. 494-502
    • Yin, H.1    Li, X.2    Zhang, B.3
  • 11
    • 84891894115 scopus 로고    scopus 로고
    • TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesis
    • Zhu J, Chen L, Shi J, Liu S, Liu Y Zheng D. TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesis. Immunology 2014; 141:211-21.
    • (2014) Immunology , vol.141 , pp. 211-221
    • Zhu, J.1    Chen, L.2    Shi, J.3    Liu, S.4    Liu, Y.5    Zheng, D.6
  • 12
    • 78650505681 scopus 로고    scopus 로고
    • KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production
    • Goettel JA, Scott AHM, Olivares-Villagomez D et al. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production. Gastroenterology 2011; 140:265-74.
    • (2011) Gastroenterology , vol.140 , pp. 265-274
    • Goettel, J.A.1    Scott, A.H.M.2    Olivares-Villagomez, D.3
  • 13
    • 84899580331 scopus 로고    scopus 로고
    • Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice
    • de Chambrun GP, Body-Malapel M Frey-Wagner I et al. Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal Immunol 2014; 7:589-601.
    • (2014) Mucosal Immunol , vol.7 , pp. 589-601
    • de Chambrun, G.P.1    Body-Malapel, M.2    Frey-Wagner, I.3
  • 16
    • 68849084141 scopus 로고    scopus 로고
    • IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
    • Jones JL, Phuah CL, Cox AL et al. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H). J Clin Invest 2009; 119:2052-61.
    • (2009) J Clin Invest , vol.119 , pp. 2052-2061
    • Jones, J.L.1    Phuah, C.L.2    Cox, A.L.3
  • 17
    • 84862677418 scopus 로고    scopus 로고
    • Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis
    • Rao SP, Sancho J, Campos-Rivera J et al. Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis. PLoS One 2012; 7:e39416.
    • (2012) PLoS One , vol.7 , pp. e39416
    • Rao, S.P.1    Sancho, J.2    Campos-Rivera, J.3
  • 18
    • 84862908724 scopus 로고    scopus 로고
    • Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia
    • Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Wu CO, Young NS. Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood 2012; 119:345-54.
    • (2012) Blood , vol.119 , pp. 345-354
    • Scheinberg, P.1    Nunez, O.2    Weinstein, B.3    Scheinberg, P.4    Wu, C.O.5    Young, N.S.6
  • 19
    • 84869507357 scopus 로고    scopus 로고
    • Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
    • Coles AJ, Twyman CL, Arnold DL et al. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 2012; 380:1829-39.
    • (2012) Lancet , vol.380 , pp. 1829-1839
    • Coles, A.J.1    Twyman, C.L.2    Arnold, D.L.3
  • 20
    • 84869492471 scopus 로고    scopus 로고
    • Alemtuzumab versus interferon β1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
    • Cohen JA, Coles AJ, Arnold DL et al. Alemtuzumab versus interferon β1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 2012; 380:1819-28.
    • (2012) Lancet , vol.380 , pp. 1819-1828
    • Cohen, J.A.1    Coles, A.J.2    Arnold, D.L.3
  • 21
    • 79958863377 scopus 로고    scopus 로고
    • Antimouse CD52 monoclonal antibody inhibits established spontaneous colitis in IL-10-deficient mice
    • Zhu WM, Li Y, Yu C, Li N, Li JS. Antimouse CD52 monoclonal antibody inhibits established spontaneous colitis in IL-10-deficient mice. Inflamm Bowel Dis 2011; 17:E72-3.
    • (2011) Inflamm Bowel Dis , vol.17 , pp. E72-E73
    • Zhu, W.M.1    Li, Y.2    Yu, C.3    Li, N.4    Li, J.S.5
  • 22
    • 84899689659 scopus 로고    scopus 로고
    • Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice
    • Wang H, Dong J, Zuo L et al. Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice. Br J Nutr 2014; 111:987-95.
    • (2014) Br J Nutr , vol.111 , pp. 987-995
    • Wang, H.1    Dong, J.2    Zuo, L.3
  • 25
    • 79960919901 scopus 로고    scopus 로고
    • Control of TH17 cells occurs in the small intestine
    • Esplugues E, Huber S, Gagliani N et al. Control of TH17 cells occurs in the small intestine. Nature 2011; 475:514-8.
    • (2011) Nature , vol.475 , pp. 514-518
    • Esplugues, E.1    Huber, S.2    Gagliani, N.3
  • 27
    • 84877970588 scopus 로고    scopus 로고
    • Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury
    • Wang H, Zhang W, Zuo L et al. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr 2013; 109:1990-8.
    • (2013) Br J Nutr , vol.109 , pp. 1990-1998
    • Wang, H.1    Zhang, W.2    Zuo, L.3
  • 28
    • 80051926938 scopus 로고    scopus 로고
    • Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C ζ
    • Wu LL, Chiu HD, Peng WH et al. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C ζ. Crit Care Med 2011; 39:2087-98.
    • (2011) Crit Care Med , vol.39 , pp. 2087-2098
    • Wu, L.L.1    Chiu, H.D.2    Peng, W.H.3
  • 29
    • 84896042427 scopus 로고    scopus 로고
    • Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation
    • Wang H, Zhang W, Zuo L et al. Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation. Lett Appl Microbiol 2014; 58:384-92.
    • (2014) Lett Appl Microbiol , vol.58 , pp. 384-392
    • Wang, H.1    Zhang, W.2    Zuo, L.3
  • 30
    • 79958277385 scopus 로고    scopus 로고
    • IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
    • Geremia A, Arancibia-Carcamo CV, Fleming MP et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208:1127-33.
    • (2011) J Exp Med , vol.208 , pp. 1127-1133
    • Geremia, A.1    Arancibia-Carcamo, C.V.2    Fleming, M.P.3
  • 31
    • 70049093126 scopus 로고    scopus 로고
    • Translating inflammatory bowel disease research into clinical medicine
    • Neurath MF, Finotto S. Translating inflammatory bowel disease research into clinical medicine. Immunity 2009; 31:357-61.
    • (2009) Immunity , vol.31 , pp. 357-361
    • Neurath, M.F.1    Finotto, S.2
  • 32
    • 77950588683 scopus 로고    scopus 로고
    • Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity
    • Weber CR, Raleigh DR, Su L et al. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 2010; 285:12037-46.
    • (2010) J Biol Chem , vol.285 , pp. 12037-12046
    • Weber, C.R.1    Raleigh, D.R.2    Su, L.3
  • 33
    • 53749106751 scopus 로고    scopus 로고
    • The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice
    • Wei X, Gong J, Zhu J et al. The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice. Clin Immunol 2008; 129:211-8.
    • (2008) Clin Immunol , vol.129 , pp. 211-218
    • Wei, X.1    Gong, J.2    Zhu, J.3
  • 34
    • 84904242872 scopus 로고    scopus 로고
    • Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice
    • Dong J, Wang H, Wu G et al. Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice. Clin Exp Immunol 2014; 177:94-101.
    • (2014) Clin Exp Immunol , vol.177 , pp. 94-101
    • Dong, J.1    Wang, H.2    Wu, G.3
  • 36
    • 79959271087 scopus 로고    scopus 로고
    • Intestinal homeostasis and its breakdown in inflammatory bowel disease
    • Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306.
    • (2011) Nature , vol.474 , pp. 298-306
    • Maloy, K.J.1    Powrie, F.2
  • 37
    • 24144465134 scopus 로고    scopus 로고
    • Epithelial barrier function in vivo is sustained despite gaps in epithelial layers
    • Watson AJ, Chu S, Sieck L et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 2005; 129:902-12.
    • (2005) Gastroenterology , vol.129 , pp. 902-912
    • Watson, A.J.1    Chu, S.2    Sieck, L.3
  • 38
    • 84880026950 scopus 로고    scopus 로고
    • Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
    • Vandenbroucke RE, Dejonckheere E, Van Hauwermeiren F et al. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med 2013; 5:1000-16.
    • (2013) EMBO Mol Med , vol.5 , pp. 1000-1016
    • Vandenbroucke, R.E.1    Dejonckheere, E.2    Van Hauwermeiren, F.3
  • 39
    • 73949105149 scopus 로고    scopus 로고
    • Epithelial NF-κB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation
    • Tang Y, Clayburgh DR, Mittal N et al. Epithelial NF-κB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am J Pathol 2010; 176:158-67.
    • (2010) Am J Pathol , vol.176 , pp. 158-167
    • Tang, Y.1    Clayburgh, D.R.2    Mittal, N.3
  • 40
    • 84857682579 scopus 로고    scopus 로고
    • Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
    • Hering NA, Fromm M, Schulzke JD. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 2012; 590:1035-44.
    • (2012) J Physiol , vol.590 , pp. 1035-1044
    • Hering, N.A.1    Fromm, M.2    Schulzke, J.D.3
  • 41
    • 33845995125 scopus 로고    scopus 로고
    • Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
    • Zeissig S, Burgel N, Gunzel D et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56:61-72.
    • (2007) Gut , vol.56 , pp. 61-72
    • Zeissig, S.1    Burgel, N.2    Gunzel, D.3
  • 42
    • 84897985897 scopus 로고    scopus 로고
    • Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
    • Vivinus-Nebot M, Frin-Mathy G, Bzioueche H et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014; 63:744-52.
    • (2014) Gut , vol.63 , pp. 744-752
    • Vivinus-Nebot, M.1    Frin-Mathy, G.2    Bzioueche, H.3
  • 43
    • 84878667737 scopus 로고    scopus 로고
    • Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
    • Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F, Baumgart DC. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2013; 304:G970-9.
    • (2013) Am J Physiol Gastrointest Liver Physiol , vol.304 , pp. G970-G979
    • Fischer, A.1    Gluth, M.2    Pape, U.F.3    Wiedenmann, B.4    Theuring, F.5    Baumgart, D.C.6
  • 44
    • 80054716832 scopus 로고    scopus 로고
    • Increase in the tight junction protein claudin-1 in intestinal inflammation
    • Poritz LS, Harris LR 3rd, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 2011; 56:2802-9.
    • (2011) Dig Dis Sci , vol.56 , pp. 2802-2809
    • Poritz, L.S.1    Harris 3rd, L.R.2    Kelly, A.A.3    Koltun, W.A.4
  • 45
    • 30944443377 scopus 로고    scopus 로고
    • Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease
    • Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 2006; 86:191-201.
    • (2006) Lab Invest , vol.86 , pp. 191-201
    • Blair, S.A.1    Kane, S.V.2    Clayburgh, D.R.3    Turner, J.R.4
  • 46
    • 33749466490 scopus 로고    scopus 로고
    • IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction
    • Wang F, Schwarz BT, Graham WV et al. IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006; 131:1153-63.
    • (2006) Gastroenterology , vol.131 , pp. 1153-1163
    • Wang, F.1    Schwarz, B.T.2    Graham, W.V.3
  • 47
    • 19144364861 scopus 로고    scopus 로고
    • Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes
    • Waschke KA, Villani AC, Vermeire S et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol 2005; 100:1126-33.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1126-1133
    • Waschke, K.A.1    Villani, A.C.2    Vermeire, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.